PrednisoneMetered Dose InhalersDry Powder InhalersNebulizers and VaporizersAdministration, InhalationChlorofluorocarbonsAerosol PropellantsPowdersBronchodilator AgentsAlbuterolAerosolsAsthmaInhalation SpacersAnti-Asthmatic AgentsBeclomethasoneVincristineBudesonideGlucocorticoidsHydrocarbons, FluorinatedIpratropiumPregnadienediolsCyclophosphamideEthanolaminesFenoterolTerbutalineRespiratory System AgentsEquipment DesignTreatment OutcomeAdrenal Cortex HormonesDoxorubicinAnti-Inflammatory AgentsRespiratory TherapyForced Expiratory VolumeDrug Therapy, CombinationPulmonary Disease, Chronic ObstructiveDouble-Blind MethodProcarbazineAntineoplastic Combined Chemotherapy ProtocolsDrug Administration SchedulePeak Expiratory Flow RateMechlorethamineCross-Over StudiesPregnenedionesPrednisoloneAzathioprineImmunosuppressive AgentsChlorofluorocarbons, MethaneAndrostadienesParticle SizeAdrenergic beta-AgonistsScopolamine DerivativesMelphalanMitoxantroneAntibodies, Monoclonal, Murine-DerivedPatient Education as TopicBleomycinMethotrexateDrug CombinationsColor TherapyDrug Delivery SystemsRemission InductionChemistry, PharmaceuticalAdministration, OralTherapeutic EquivalencyChlorambucilCromolyn SodiumLymphoma, Non-HodgkinFollow-Up StudiesAdrenergic beta-2 Receptor AgonistsLung Diseases, ObstructivePatient ComplianceCyclosporineDose-Response Relationship, DrugHodgkin DiseaseCholinergic AntagonistsLymphoma, Large B-Cell, DiffuseHoarsenessMycophenolic AcidTime FactorsTechnology, PharmaceuticalRespiratory Function TestsVinblastineInspiratory CapacityAsparaginaseMaximal Expiratory Flow RateHydrocortisoneThalidomideMultiple MyelomaLungKidney TransplantationMaintenance ChemotherapyVital CapacityClinical Trials as TopicOzone DepletionAtropine DerivativesEtoposideSelf AdministrationPatient PreferenceSurvival AnalysisBronchial Spasm